Last week, an expert panel of physicians in China published an article titled Chinese Consensus Statement on the Evaluation and Intervention of Collateral Circulation for Ischemic Stroke under a Clinical Guideline in CNS Neuroscience & Therapeutics, a peer reviewed scientific journal. The article is based on the group’s review of the most up-to-date evidence-based clinical research and their state-of-the-art, scientific knowledge on ischemic stroke.
In their summary, the authors make the point that “Collateral circulation is becoming more significant in the individual management strategy for ischemic stroke…” and that current data has been recently updated to reflect this. They further note – in the section discussing Indirect Interventions that External Counterpulsation “…increases cardiac output and augments blood flow of vital organs, such as brain, kidney, liver, and myocardium.”
One of the additional recent updates is the inclusion of EECP (Enhanced External Counterpulsation) Therapy in the 2012 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, with a IIb Level of Recommendation (LOR).
Though the use of EECP Therapy is not yet an approved Indication for Use by the U.S. Food and Drug Administration, recently published papers show that recognition of the clinical benefits of EECP Therapy in treating stroke patients by experts in the field are encouraging that one day, in the not too distant future, it will be.